Inovalon Launches InfectionWatch For The Provider Marketplace
Inovalon, a leading provider of cloud-based platforms empowering data-driven healthcare, announced today the launch of InfectionWatch, an infection surveillance and reporting solution that provides healthcare facilities with data-driven insights to empower real-time identification of infections demonstrating antibiotic resistance and virus outbreaks such as COVID-19. This reporting solution helps facilities meet regulatory compliance requirements and empowers them to improve quality outcomes with greater efficiency and confidence.
The Centers for Medicare and Medicaid Services (CMS) requires all healthcare facilities and providers to effectively manage the identification, reporting, investigating and control of infectious and communicable diseases applicable to residents, staff, volunteers, visitors and others with access to facilities. The current COVID-19 pandemic has increased CMS’ regulatory compliance oversight with these requirements driving increased market demand for an analytically driven platform that ensures effective monitoring and regulatory compliance.
Recommended AI News: Simplify Deploys 8×8 for Enhanced Collaboration and Engagement
InfectionWatch™, a Module of the Inovalon ONE® Platform brought to market through the ABILITY provider network, leverages real-time EHR data and predictive analytics to enable seamless monitoring and tracking of infections, providing detailed evaluations of infection trends by category, type and culture organism, as well as predictive insights into patient-specific and infection-specific progressions and risk rates. Additional capabilities of the offering allow provider facilities to track the presence and prevalence of healthcare-acquired infections (HAIs), community-acquired infections (CAIs), and “present on admission” infections to identify and recommend appropriate and timely prevention interventions. Leveraging this comprehensive analytical insight, facilities can track targeted infections, identify potential cases of antimicrobial resistance, monitor and report adverse events, and deploy more effective infection control measures.
“Given the heightened focus on infection prevalence, tracking, and treatment within the marketplace, we are excited to offer InfectionWatch™ to our provider network to help them improve both patient care and infection control,” said Bud Meadows, president and general manager of Inovalon’s provider business. “This new capability comes at an important time for our clients and we are pleased to be seeing strong market demand.”